abiraterone

Can Pharma Influence Physician Prescribing? Unleashing New Data Using Prostate Cancer Drugs
Forbes
Sat, 08/5/17 - 09:46 am
physicians
prostate cancer
abiraterone
Enzalutamide
physician payments
AstraZeneca to co-promote J&J prostate cancer drug in Japan
Yahoo/Reuters
Fri, 10/11/13 - 08:47 am
JNJ
AstraZeneca
Japan
prostate cancer
abiraterone
Exelixis announces initiation of trial combining cabozantinib, abiraterone
Yahoo/Fly on the Wall
Mon, 03/5/12 - 11:12 am
Exelixis
cabozantinib
abiraterone
prostate cancer
A Quick Roundup Of The New Drugs Presented At This Weekend's Huge Oncology Conference
Yahoo/Business Insider
Mon, 06/6/11 - 10:25 am
ASCO
Amgen
Aveo Pharmaceutical
Celgene
Medivation
tivozanib
abiraterone
Abraxane
AMG 479
Revlimid
Abiraterone vs. MDV3100: A prostate cancer drug showdown
Fierce Biotech
Thu, 05/19/11 - 02:08 pm
abiraterone
prostate cancer
Medivation
MDV3100
dimebon
Pfizer
Astellas
Johnson & Johnson Prostate Cancer Drug Approved by U.S. FDA
Bloomberg
Thu, 04/28/11 - 10:00 pm
prostate cancer
JNJ
FDA
abiraterone
Comparing Medivation, Inc.'s and Johnson & Johnson's Prostate Cancer Drugs
Seeking Alpha
Mon, 03/21/11 - 02:56 pm
prostate cancer
Medivation
JNJ
Pfizer
Astellas
MDV3100
abiraterone
For Dendreon’s Provenge, a New Competitor Looms
WSJ Online
Tue, 10/12/10 - 11:07 am
Dendreon
Provenge
prostate cancer
abiraterone
JNJ
J&J Drug for Prostate Cancer Extends Life in Company-Sponsored Research
Bloomberg
Mon, 10/11/10 - 11:17 am
JNJ
prostate cancer
abiraterone
J&J Expands Options For Prostate Cancer
Yahoo/Investor's Business Daily
Sat, 09/25/10 - 12:08 pm
JNJ
prostate cancer
abiraterone
Provenge
Dendreon
J&J Prostate Cancer Drug Boosts Survival
TheStreet.com
Fri, 09/10/10 - 11:07 am
JNJ
prostate cancer
abiraterone
Dendreon
Provenge
J&J's prostate cancer drug proves promising in Ph2
Fierce Biotech
Wed, 02/17/10 - 06:55 pm
prostate cancer
JNJ
abiraterone